Thiophene sulfoximines, compositions thereof, and methods of treating complement-mediated diseases and conditions

US7385066B2 · kind B2 · utility

Assignee

• Janssen Pharmaceutica NA · BE

Inventors

• Nalin Subasinghe · Exton, US
• Shelley K. Ballentine · Lansdale, US
• Jeremy Travins · Southborough, US
• Ehab M. Khalil · Yorktown, US
• Farah Ali · Exton, US
• Kristi A. Leonard · West Chester, US
• Joan Gushue · Harleysville, US
• Michael Winters · Morgantown, US
• Heather Rae Hufnagel · Glenmoore, US
• Maxwell D. Cummings · Strafford, US

Key dates

• Filing date: Mar 14, 2006
• Grant date: Jun 10, 2008
• Expiry date: Mar 14, 2026

Classification

• Technology area (CPC C): Chemistry; Metallurgy
• CPC primary: C07D417/12
• WIPO field: Pharmaceuticals
• WIPO sector: Chemistry

Abstract

Disclosed are compounds for treating the symptoms of an acute or chronic disorder mediated by the classical pathway of the complement cascade. The compounds are of Formula Ior a solvate, hydrate, pharmaceutically acceptable salt, or prodrug thereof; wherein Ra, Rb, and Rc are defined in the specification, as are A Z, Q, R1 and R2.